Living Hope

It was a meaningful look back at 10 years of progress, empowerment, and hope—and an inspiring look ahead at what the next decade may bring for Let’s Win and the pancreatic cancer community.  Congratulations to the entire Let’s Win Pancreatic Cancer family on 10 incredible years! #LivingHope #PancreaticCancer #LetsWinPancreaticCancer #PancreaticCancerResearch #PatientEmpowerment #PatientAdvocacy #CancerResearch #Hope

Ashley Baylor, founder of The Baylor Strong Project, a platform supporting pancreatic cancer caregivers through education, community, and practical resources. Inspired by her own experience caring for her father, Ashley has created tools including the CareGuide app, Caregiver’s Corner newsletter, and Beyond the Diagnosis YouTube series to help families navigate pancreatic cancer with greater clarity, confidence, and connection. She also works as a consultant to families facing serious illness. #LivingHope #PancreaticCancer #PancreaticCancerAwareness #CancerSurvivor #CancerAdvocacy #TheBaylorStrongProject #Caregivers

Burt Rosen returns to Living Hope: Your Journey with Pancreatic Cancer to continue our conversation—this time focusing on how artificial intelligence is changing the patient experience. Burt shares how he uses AI to better understand medical records and scan results, track symptoms, prepare for appointments, and ask better questions of his medical team. We also explore the benefits and limitations of AI, privacy concerns, and Burt’s vision of the patient, physician, and AI working together—while remembering that AI is a tool, not a replacement for trusted medical care. It’s a fascinating conversation about technology, patient advocacy, and empowering patients to become more informed partners in their own care. #LivingHopePodcast #PancreaticCancer #PancreaticCancerAwareness #PatientAdvocacy #CancerSurvivorship #AIinHealthcare #PatientEmpowerment 

Tori Larrick, Associate Director of Patient Services at PanCAN, joined Living Hope: Your Journey with Pancreatic Cancer to discuss the growing excitement surrounding daraxonrasib, what emerging treatments may mean for patients, how patients can advocate for themselves and explore treatment options, and the emotional impact of hearing about promising advances that may not yet be accessible to everyone. It’s an important conversation about hope, access, advocacy, and empowering patients with trusted information. **Since this episode aired, there has been an important development: On August 26, 2026, the FDA approved daraxonrasib, under the brand name Rasonque, for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy, as well as certain patients who are not candidates for multiagent systemic therapy.  

Nisha Patel, Nurse Practitioner at Hoag Family Cancer Institute, joins Living Hope to discuss pancreatic cancer risk, early detection, and the importance of screening for individuals with a strong family history or inherited genetic mutations. She explains who may qualify for high-risk surveillance, the guidelines used to make screening recommendations, what patients can expect from Hoag’s Pancreatic Cancer Early Detection Program, and how she works alongside Dr. Demeure to support patients throughout the process. The episode also highlights the importance of knowing your family history, understanding your personal risk, and how early detection can make a meaningful difference.